Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid

BACKGROUND: To date, patients with pre-existing autoimmune conditions have been excluded from immunotherapy trials out of concern for severe autoimmune exacerbations. CASE PRESENTATION: We describe the first case of a patient with metastatic cKIT mutated acral melanoma, brain metastasis, and pre-exi...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Kristen M., Dong, Joanna, Geskin, Larisa J., Beltrani, Vincent P., Phelps, Richard G., Carvajal, Richard D., Schwartz, Gary, Saenger, Yvonne M., Gartrell, Robyn D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835882/
https://www.ncbi.nlm.nih.gov/pubmed/27096097
http://dx.doi.org/10.1186/s40425-016-0123-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835882/
https://www.ncbi.nlm.nih.gov/pubmed/27096097
http://dx.doi.org/10.1186/s40425-016-0123-3

Ejemplares similares